China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase I Clinical Study on the Safety, Tolerability, Pharmacokinetic/Pharmacodynamic Cha... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Correlation Between Periodontitis and Its Treatment and Recurrence After... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Combined Laser and Sclerotherapy for Venous Malformations Trial'. The following are the... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study Comparing Pulsed Field Ablation With and Without Additional Superior Vena Cava ... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Functional and Mechanistic Analysis of Antiphospholipid Antibody-Induced Inhibition of ... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Study of Safety and Preliminary Efficacy of ALT001 in Patients with Mitochondrial D... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Investigation on the whole reprocessing process of digestive endoscope with special str... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effect of dexmedetomidine on perioperative electroencephalogram characteristics and... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using CNN-SLAM artificial intelligence deep learning method to develop holographic visu... Read More
China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Bimekizumab in Chinese Patients With Moderate-to-Severe Plaque P... Read More